Putnam Investments LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Putnam Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $1.17 Million - $1.23 Million	-8,095 Reduced 7.4%	101,368 $15.3 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $1.85 Million - $3.25 Million	22,240 Added 25.5%	109,463 $16 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $169,633 - $220,239	1,541 Added 1.8%	87,223 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $292,508 - $435,491	2,933 Added 3.54%	85,682 $11.8 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $2,075 - $2,917	-21 Reduced 0.03%	82,749 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $164,450 - $262,550	2,500 Added 3.11%	82,770 $8.04 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $56,675 - $85,567	-871 Reduced 1.07%	80,270 $6.88 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $5,313 - $7,015	-90 Reduced 0.11%	81,141 $5.28 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $468,917 - $1.2 Million	16,164 Added 24.84%	81,231 $5.94 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $10,178 - $21,197	-370 Reduced 0.57%	65,067 $2.22 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $2.67 Million - $3.77 Million	65,437 New	65,437 $3.56 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.